GVHD can range from mild and temporary to life-threatening and chronic — but the deadly, debilitating cases are rare now. As ...
In this episode of the Oncology Insights Podcast, Dr. Petros Grivas welcomes Dr. Christina Rodriguez to discuss her journey ...
Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...
A new $5.2 million grant from the Washington Research Foundation will help develop a new clinical trials program between Fred ...
On Oct. 9, 2025, Fred Hutch Cancer Center employees with decades of service were honored at a luncheon celebrating their ...
The Food Biomarkers Study (FBS) is a research project to help scientists learn how markers of consuming certain protein foods appear in blood and urine. The study involves three, 9-day study food ...
Affiliate Professor, Herbold Computational Biology Program, Public Health Sciences Division, Fred Hutch Affiliate Professor, Herbold Computational Biology Program Public Health Sciences Division, Fred ...
Today, Fred Hutch announced that in 2025 the Obliteride community raised $9.2 million for groundbreaking research. This amount brings Obliteride’s cumulative fundraising total to more than $67 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback